Pharmacovigilance in the Community
A world in which pharmacovigilance is understood and practiced by all members of society, patients, pharmacists, and health care providers.
Committee
Rebecca Noss, MSc
Dr. Rabia Hussain
ISoP SIGs
Pharmacovigilance in the Community
🌍 ISoP Pharmacovigilance in the Community SIG Initiative
Strengthening Medicine Safety Through Community Collaboration
The latest Uppsala Reports article, “It Takes a Community to Make Medicines Safer for All,” highlights the crucial role of collaboration in improving medicine safety worldwide. This aligns with ISoP’s Special Interest Group (SIG) initiatives, which emphasize the power of collective efforts in pharmacovigilance.
Discover how global partnerships and inclusive approaches can enhance patient safety. Read the full article here: Uppsala Reports.
📢 Join the conversation and support ISoP’s mission to strengthen pharmacovigilance through community engagement!
Pharmacovigilance Training for Health Care Providers (HCPs) and Pharmacists
Wednesday, 13 November 2024 13:00 – 14:30 UTC | 17:00 – 18:30 UAE
Siva Kumar Buddha, MBBS, MBA
Alina Panourgia, MSc
Rebecca Noss, MSc
All webinars are recorded and are available for ISoP members.
Patients are not educated about adverse drug reactions (ADRs). On a daily basis, patients pick up medications at the pharmacy without asking any questions. Pharmacy staff asks ‘Do you have any questions for the pharmacist?’ and most of the time the answer is ‘no’. Pharmacists don’t spend time explaining common ADRs to patients. This has caused potentially serious adverse drug reactions, lack of proper reporting and management of ADRs.
An adverse drug reaction is a response to a drug, which is noxious and unintended and occurs at doses normally used in humans for prophylaxis, diagnosis, or therapy of disease or for the modification of physiologic function. Note that there is a causal link between a drug and an adverse drug reaction.
Educating pharmacists and health care providers about pharmacovigilance and how to properly teach patients about the most common ADRs will help in reducing visits to the emergency room and ensure patient safety. There is a reluctance of health care providers/pharmacists to discuss ADRs prior to treatment (“they do not want to scare patients”).
Pharmacovigilance in the Community will have a close collaboration with the Risk Communication and Patient Engagement SIGs as well.
You can view the article on ISoP PV in the Community SIG in the Drug Safety Journal. The article “Pharmacovigilance in the Community: A Special-Interest Group of the International Society of Pharmacovigilance‘ outlines the creation of this new SIG, its mandate, strategies, plans, and, most importantly, its rationale, emphasizing the vital role it plays in promoting patient safety.
Vision
A world in which pharmacovigilance is understood and practiced by all members of society, patients, pharmacists, and health care providers.
Objectives
- Educate pharmacists, health care providers, and patients on pharmacovigilance ‘PV’ focused on ADRs.
- Regular contribution to patient safety day.
- Provide bi-monthly news and updates by email to Pharmacovigilance in the Community SIG members.
- Provide yearly training to pharmacists on pharmacovigilance.
- Provide pharmacists a forum for discussion of any ADR and PV questions.
- To organize where possible, a session at the ISoP mid-year or annual meeting each year on the topic of PV in the community.
- To advise the ISoP Executive Committee, where required on issues relating to patient safety.
- To foster collaboration between national pharmacovigilance centers and pharmacies.
- To develop and improve approaches to communication regarding reporting and management of ADRs. This is very important to patients and a greater recognition of the need to really engage patients in pharmacovigilance.
Guidelines on How to Become a Member of this SIG
- ISoP member. Not a member yet? please join ISoP today!
- Passion about supporting health care providers, pharmacists, and patients creating different ADR tools
- Have a connection with the pharmacist, health care provider, and patient organizations/societies in the country or the region affiliated to
Would you like to join or learn more about this new group? Contact us at administration@isoponline.org